In this study, we aimed to determine the HPV-attributable fraction in HNSCC by analyzing HPV DNA and HPV RNA status, as well as by determining the p16 expression level, within a large retrospective cohort of HNSCC cases from Northeastern Romania. The gene discussed is CDKN2A; the disease is head and neck squamous cell carcinoma.